Live Quote · NASDAQMNPRHealthcare· Biotechnology

Monopar Therapeutics Inc.

$69.00▼ 1.84%($-1.29)
MKT CAP $467.60MNEXT EARNINGS Mar 25, 2027
50%
Bullish
TickerSpark Score
43/100
▌ Weak
67
Valuation
20
Profitability
15
Growth
84
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MNPR research report →

Analyst Price Target
$126.00+82.6% vs. today

Range $105 – $145

Analyst RatingBuy
11 Buy3 Hold0 Sell

Price Chart

-15.31% · this period
$123.84$86.98$50.12Nov 19May 22Nov 19
52-Week Range25% of range
Low
$50.07
Current
$69.00
High
$124.82